|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0016022,
umls-concept:C0019134,
umls-concept:C0022116,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0032143,
umls-concept:C0034897,
umls-concept:C0155626,
umls-concept:C0175566,
umls-concept:C0205042,
umls-concept:C0239307,
umls-concept:C0332293,
umls-concept:C0441889,
umls-concept:C0521115,
umls-concept:C0596382,
umls-concept:C1257890,
umls-concept:C1707520
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1992-3-27
|
|
pubmed:abstractText |
Fibrin generation during and after therapy with alteplase may depend on the level of concomitant anticoagulation. The hypothesis that fibrinopeptide A (FPA) levels, as markers of ongoing in vivo fibrin formation, correlate with the angiographic and clinical outcome of thrombolysis is tested.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
928-34
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.
|
|
pubmed:affiliation |
Center for Thrombosis and Vascular Research, University of Leuven, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
